Humana Beats Estimates, But Shares Drop

Humanas Q1 2026 earnings beat estimates with adjusted EPS of $10.31, up from $10.19, and revenue of $39.6 billion, up from $32.1 billion. However, shares fell as much as 7% in premarket due to rising pressures like federal reimbursements lagging behind costs. The insurance side showed a benefit ratio of 89.4%, better than expected, but CenterWells primary care arm for seniors saw operating costs spike. Humanas operating cost ratio landed at 10.2%, above Wall Streets target of 9.5%. The company plans to tweak their product mix and benefits to stay profitable. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/46ba2add8118a571